Eton Pharmaceuticals, Inc. Purchase Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement by and between the Company and Ipsen Biopharmaceuticals, Inc., dated as of October 2, 2024 (portions of the exhibit have been redacted)
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2025
Asset Purchase Agreement dated December 31, 2024 between Teva Pharmaceuticals USA, Inc. and the Registrant (portions of the Exhibit have been redacted)
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
DE
2025
Form of Purchase Agreement
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
DE
2024
Asset Purchase Agreement by and among the Company and Dr. Reddys Laboratories S.A., dated as of June 24, 2022
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Purchase Agreement dated March 26, 2020 by and among the Company and Certain Investors
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2020
Securities Purchase Agreement dated March 26, 2020 by and between the Company and Opaleye L.P
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2020
Asset Purchase Agreement (DS-200) dated June 23, 2017 between Selenix, LLC and the Registrant
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
CA
2018
Asset Purchase and License Agreement (CT-200) dated May 9, 2017 between Imprimis Pharmaceuticals, Inc. and the Registrant
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
CA
2018
Asset Purchase and License Agreement (CT-100) dated May 9, 2017 between Imprimis Pharmaceuticals, Inc. and the Registrant
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
CA
2018
Securities Purchase Agreement dated June 19, 2017 by and among the Registrant and the Buyers named therein
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018